
Loading, please wait...

Loading, please wait...

Postmenopausal women often experience a higher incidence of hypertension compared to men of similar age groups. Consequently, doctors notice significant health risks in this demographic. Because estrogen levels decline during menopause, several physiological changes occur. For instance, hypocalcemia often develops and contributes to the progression of high blood pressure. Therefore, a recent study investigated the impact of calcium supplementation hypertension management in women with these conditions.
Specifically, researchers prospectively included 300 postmenopausal women diagnosed with both hypertension and hypocalcemia. Similarly, each participant received 1,000 mg of calcium carbonate daily in two divided doses. In addition, they maintained their standard antihypertensive treatments. Meanwhile, the medical team recorded serum calcium and blood pressure levels at baseline and after three months. After the follow-up period, the team analyzed the clinical outcomes. Overall, the findings provided valuable insights for clinical practice.
Furthermore, the results showed clear benefits for patients who achieved normocalcemia. Although some women remained hypocalcemic, those with normalized calcium levels saw significantly better results. Specifically, their systolic and diastolic blood pressures dropped substantially. Moreover, more patients in this group reached their target blood pressure goals. Thus, the successful correction of calcium deficiency appears crucial for cardiovascular health. Consequently, clinicians should monitor serum calcium levels in hypertensive postmenopausal patients. Indeed, this approach helps optimize blood pressure management. Additionally, researchers noted that younger age at menopause was associated with persistent hypocalcemia. In contrast, older age at menopause linked to better recovery of calcium levels. Finally, the study concluded that supplementation serves as a helpful adjunct therapy.
Yes, the study indicates that using calcium supplements to correct hypocalcemia in postmenopausal women can significantly reduce systolic and diastolic blood pressure when added to standard treatment.
Participants received 1,000 mg of calcium carbonate daily, administered in two separate doses of 500 mg each.
Research suggests that women who enter menopause at a younger age may be more likely to experience persistent hypocalcemia compared to those who enter menopause later.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a physician or other qualified health provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Alaarag AF et al. The impact of calcium supplementation on hypertension management in postmenopausal women with hypocalcemia. BMC Nutr. 2026 Jun 19. doi: 10.1186/s40795-026-01377-2. PMID: 42321952.
2. Mayo Clinic. Calcium supplements: Do they interfere with blood pressure drugs? Accessed June 20, 2026.
3. NIH Office of Dietary Supplements. Calcium: Fact Sheet for Health Professionals. Accessed June 20, 2026.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This study investigates how 1,000 mg/day of calcium carbonate supplementation helps manage hypertension and correct hypocalcemia in postmenopausal women, leading to better blood pressure control.
2 months ago

A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today